Crossmark

Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

Crossref DOI link: https://doi.org/10.1186/s13075-024-03357-y

Published Online: 2024-07-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Narvaez, Javier https://orcid.org/0000-0002-1614-8064
Canadillas, Elena

Castellvi, Ivan https://orcid.org/0000-0002-5410-5807
Alegre, Juan Jose https://orcid.org/0000-0003-1641-0875
Vicens‑Zygmunt, Vanesa

Bermudo, Guadalupe

Vidal-Montal, Paola

Molina Molina, Maria https://orcid.org/0000-0002-1852-1723
Nolla, Joan Miquel https://orcid.org/0000-0002-2358-6767
License Information

Text and Data Mining valid from 2024-07-09

Version of Record valid from 2024-07-09
More Information

Article History

First Online: 9 July 2024